- Home
- AFRM vs FMS Comparison
AFRM vs FMS Comparison
Compare AFRM & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFRM
- FMS
- Stock Information
- Founded
- AFRM 2012
- FMS 1996
- Country
- AFRM United States
- FMS Germany
- Employees
- AFRM N/A
- FMS N/A
- Industry
- AFRM Business Services
- FMS Misc Health and Biotechnology Services
- Sector
- AFRM Consumer Discretionary
- FMS Health Care
- Exchange
- AFRM Nasdaq
- FMS Nasdaq
- Market Cap
- AFRM 16.1B
- FMS 13.8B
- IPO Year
- AFRM 2021
- FMS 1996
- Fundamental
- Price
- AFRM $54.26
- FMS $28.08
- Analyst Decision
- AFRM Buy
- FMS Hold
- Analyst Count
- AFRM 22
- FMS 1
- Target Price
- AFRM $66.79
- FMS $25.00
- AVG Volume (30 Days)
- AFRM 6.6M
- FMS 482.7K
- Earning Date
- AFRM 05-08-2025
- FMS 05-06-2025
- Dividend Yield
- AFRM N/A
- FMS 2.26%
- EPS Growth
- AFRM N/A
- FMS 27.83
- EPS
- AFRM N/A
- FMS 2.28
- Revenue
- AFRM $2,800,203,000.00
- FMS $21,068,786,202.00
- Revenue This Year
- AFRM $39.43
- FMS $3.18
- Revenue Next Year
- AFRM $24.51
- FMS $3.62
- P/E Ratio
- AFRM N/A
- FMS $25.08
- Revenue Growth
- AFRM 46.27
- FMS 0.10
- 52 Week Low
- AFRM $22.25
- FMS $17.93
- 52 Week High
- AFRM $82.53
- FMS $25.96
- Technical
- Relative Strength Index (RSI)
- AFRM 63.77
- FMS 71.86
- Support Level
- AFRM $50.03
- FMS $25.55
- Resistance Level
- AFRM $53.26
- FMS $28.59
- Average True Range (ATR)
- AFRM 2.41
- FMS 0.40
- MACD
- AFRM 1.09
- FMS 0.41
- Stochastic Oscillator
- AFRM 90.82
- FMS 90.40
About AFRM Affirm Holdings Inc.
Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three quarters of sales while the balance is generated from medical technology products that enable dialysis treatments.